Facebook Linkedin Twitter

Tumor necrosis factor

IBD, Crohn's disease, ulcerative colitis
News & Features

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

Malorye Branca -
0
Photograph illust
News & Features

Some Causes of Inflammation May Protect Against Cognitive Decline

Helen Albert -
0
Diseased colon, illustration
News & Features

New Insights into Genetics of Crohn’s Disease Could Help Non-Responsive Patients

Helen Albert -
0
Coronavirus structure
Coronavirus

Inflammatory Status Crucial for Predicting Prognosis in Cancer Patients with COVID-19

Helen Albert -
0
Asian doctor in PPE medical suit with an injection vaccine and infusion drip for covid-19 or corona virus patient
Coronavirus

Trial Suggests Arthritis Drug Has No Benefits for COVID-19 Patients

Helen Albert -
0
Female doctor checking on Covid-19 infected patient while connected to a ventilator
Coronavirus

High Levels of IL-6 and TNF-α Proteins in Blood Predict Worse COVID-19 Outcomes

Helen Albert -
0

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine